Corus Orthodontists Welcomes Two New Board Directors, Celebrates Leadership Continuity, and Eyes Future Growth
Article content
TORONTO — Corus Orthodontists, a leading North American orthodontic partnership network, is pleased to announce the election of Tim Patterson, a seasoned healthcare investor, and Dr. Nicole Nalchajian, a Corus Doctor-Partner, to its Board of Directors. These appointments reinforce Corus's continued commitment to combining business expertise with clinical excellence as it scales across North America.
Article content
Article content
Corus also expresses its sincere appreciation to Dr. Sharon Nguyen and Jill Nowak, who are retiring from the Board at the end of their terms after years of dedicated service. Both played instrumental roles in shaping Corus's robust governance and operational foundation.
Article content
New Board Appointments
Article content
Tim Patterson brings over 25 years of experience in private equity and healthcare investing. He formerly led OMERS Private Equity's healthcare investments and served as Vice Chair of its Investment Committee. During his 11-year tenure at OMERS, he was a director of several healthcare companies, including Premise Health, Forefront Dermatology, and CBI Health Group, among others. Now an independent advisor and investor, Patterson brings a strategic lens to scaling healthcare partnerships.
Article content
'I'm thrilled to join the Board of Corus Orthodontists,' said Patterson. 'The company is uniquely positioned with a values-based culture and a high-performing management team that blends operational excellence with clinical integrity. I am especially excited to work with Dr. Paul Helpard, the company's visionary Founder and Strategic Advisor, and Dean Prevost, an accomplished and thoughtful CEO, as well as the rest of the Board and leadership team, as we guide Corus into its next phase of growth.'
Article content
Dr. Nicole Nalchajian is a practicing orthodontist and Doctor-Partner at Nalchajian Orthodontics in Fresno and Clovis, California. Since joining Corus in 2022, she has been a vocal advocate for clinical collaboration, continuous learning, and enhancing the patient experience.
Article content
'Becoming part of the Corus network has been one of the most rewarding steps in my professional journey,' said Dr. Nalchajian. 'The network provides best-in-class mentorship and support. As a Doctor-Partner, I have seen firsthand how Corus empowers clinicians to focus on exceptional patient care while being part of a collaborative, doctor-led community. I am honoured to bring that perspective to the Board.'
Article content
Tim and Dr. Nalchajian join a highly accomplished Board of Directors, comprised of Alan Torrie, Dr. Warren Cohen, Dr. Michael Goldstein, Dr. Paul Helpard, Dr. Shawn Russett, Dr. Lesley Williams, Chris Gardner and Brent Houlden.
Article content
Dr. Fran Short, a practicing orthodontist and Doctor-Partner at Short Orthodontics in Linwood, New Jersey, has also recently been appointed as a Board Observer.
Article content
Leadership Reflections and Welcomes
Article content
Board Chair Alan Torrie welcomed the new directors, emphasizing their diverse contributions and expertise. 'We're excited to welcome Tim and Nicole to the Board,' said Torrie. 'Tim's strategic insight and deep healthcare experience will be invaluable as we continue to scale, and Nicole's perspective as a respected Doctor-Partner ensures strong alignment between our practices and Home Office teams. We also extend heartfelt thanks to Sharon and Jill for their outstanding contributions during Corus's critical growth years.'
Article content
Chris Gardner, independent Corus director and former Chief Executive Officer of Neighbourly Pharmacy, emphasized that the Board additions come at a pivotal moment for the organization. 'Corus has entered 2025 with strong momentum and a clear purpose. We have a differentiated doctor-owned and doctor-led partnership model, an aligned doctor community, an incredible culture, a strong balance sheet, and a leadership team that is second to none. With these key Board additions, we are even better positioned to lead the next chapter of growth in orthodontics.'
Article content
Dean Prevost, Corus Chief Executive Officer, shared his perspective on what sets the network apart and where it's headed next. 'Backed by strong operational and financial performance across our network and a proven playbook for delivering the Corus value proposition, we are uniquely suited to welcome like-minded Doctor-Partners and Associate Doctors into our purpose-driven, high-performing network.'
Article content
Founded in 2019, Corus Orthodontists Inc. is a North American orthodontic partnership network that offers an alternative to traditional dental and orthodontic service organizations. The company supports doctor ownership and clinical autonomy while delivering operational, financial, and strategic expertise. With over 65 Doctor-Partners and 75+ locations across 13 U.S. states and 5 Canadian provinces, Corus is one of the fastest-growing orthodontic networks in North America.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
41 minutes ago
- CBC
Society representing P.E.I. doctors is suing Health P.E.I. over new targets for family physicians
Health P.E.I. is planning to change how family physicians are expected to work in the province. The Medical Society of P.E.I. says that was not part of negotiations that led up to a new Physician Services Agreement, so it has initiated legal action, saying some doctors will leave the province over this. CBC's Stacey Janzer reports.


Globe and Mail
an hour ago
- Globe and Mail
New Buy Rating for Broadcom (AVGO), the Technology Giant
Mizuho Securities analyst Vijay Rakesh reiterated a Buy rating on Broadcom (AVGO – Research Report) yesterday and set a price target of $310.00. The company's shares closed yesterday at $259.93. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Rakesh is a 5-star analyst with an average return of 11.8% and a 49.30% success rate. Rakesh covers the Technology sector, focusing on stocks such as Nvidia, Advanced Micro Devices, and Broadcom. Currently, the analyst consensus on Broadcom is a Strong Buy with an average price target of $256.04. The company has a one-year high of $265.43 and a one-year low of $128.50. Currently, Broadcom has an average volume of 29.27M. Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AVGO in relation to earlier this year. Most recently, in April 2025, Mark David Brazeal, the Chief Legal & Corp Affairs Ofc of AVGO sold 25,000.00 shares for a total of $4,500,000.00.


CTV News
an hour ago
- CTV News
$5M ad campaign to recruit U.S. doctors and nurses
Vancouver Watch The B.C. government has launched a $5-million ad campaign aimed at recruiting American doctors and nurses.